Aytu Biopharma, Inc
AYTU- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001385818
No open-market purchases or sales by Aytu Biopharma, Inc insiders were filed in the last 90 days; 38 institutions reported holding it in 13F filings for Q2 2026, worth $8.25M in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Aytu Biopharma, Inc as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 42
- −11 vs. Q3 2022
- Shares held
- 8.05M
- −809.9K (−9.1%) vs. Q3 2022
- Total value
- $1.52M
- −$117.7K (−7.2%) vs. Q3 2022
- New holders
- 4
- 13 more added
- Sold out
- 15
- 10 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AYTU on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 38 | $8.25M |
| Q1 2026 | 37 | $10.7M |
| Q4 2025 | 39 | $9.81M |
| Q3 2025 | 33 | $6.73M |
| Q2 2025 | 32 | $7.45M |
| Q1 2025 | 31 | $2.49M |
| Q4 2024 | 29 | $3.19M |
| Q3 2024 | 24 | $4.81M |
| Q2 2024 | 27 | $5.99M |
| Q1 2024 | 27 | $5.46M |
| Q4 2023 | 22 | $5.02M |
| Q3 2023 | 22 | $4.65M |
| Q2 2023 | 21 | $2.73M |
| Q1 2023 | 21 | $1.21M |
| Q4 2022 | 42 | $1.52M |
| Q3 2022 | 53 | $1.64M |
| Q2 2022 | 41 | $2.50M |
| Q1 2022 | 44 | $6.02M |
| Q4 2021 | 46 | $5.10M |
| Q3 2021 | 49 | $12.2M |
| Q2 2021 | 61 | $26.0M |
| Q1 2021 | 72 | $48.4M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Aytu Biopharma, Inc; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Renaissance Technologies LLC | 2,140,782 | $405.0K | 0.00% | +393,262+22.5% | Added |
| Alyeska Investment Group, L.P. | 1,500,000 | $283.5K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 1,189,958 | $225.0K | 0.00% | +780,116+190.3% | Added |
| Vanguard Group Inc | 973,435 | $184.0K | 0.00% | +736+0.1% | Added |
| BlackRock Inc. | 481,195 | $90.9K | 0.00% | −555−0.1% | Reduced |
| Acadian Asset Management LLC | 397,936 | $75.0K | 0.00% | +397,936 | New |
| Commonwealth Equity Services, LLC | 309,558 | $58.0K | 0.00% | +100,000+47.7% | Added |
| Geode Capital Management, LLC | 240,815 | $46.0K | 0.00% | −736−0.3% | Reduced |
| Prudential Financial Inc | 179,550 | $33.9K | 0.00% | +34,000+23.4% | Added |
| Allred Capital Management, LLC | 125,000 | $23.6K | 0.01% | +20,000+19.0% | Added |
| State Street Corp | 97,684 | $18.5K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 91,887 | $17.4K | 0.00% | +78,348+578.7% | Added |
| Citigroup Inc | 52,369 | $9.90K | 0.00% | +52,368+5,236,800.0% | Added |
| Northern Trust Corp | 46,593 | $8.81K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 40,190 | $7.60K | 0.00% | −400−1.0% | Reduced |
| Tower Research Capital LLC (TRC) | 32,267 | $6.00K | 0.00% | −17,837−35.6% | Reduced |
| Two Sigma Advisers, LP | 24,300 | $4.59K | 0.00% | −800−3.2% | Reduced |
| Morgan Stanley | 20,491 | $3.87K | 0.00% | +60.0% | Added |
| Sigma Planning Corp | 16,996 | $3.21K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 14,917 | $2.82K | 0.00% | −11,486−43.5% | Reduced |
| Affinity Capital Advisors, LLC | 11,415 | $2.16K | 0.00% | 00.0% | Unchanged |
| Hunter Associates Investment Management LLC | 10,880 | $2.00K | 0.00% | 00.0% | Unchanged |
| HRT Financial LP | 15,596 | $2.00K | 0.00% | +15,596 | New |
| Bank of New York Mellon Corp | 10,414 | $1.97K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 6,080 | $1.00K | 0.00% | −100−1.6% | Reduced |
| Ronald Blue Trust, Inc. | 5,579 | $1.00K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 5,218 | $991 | 0.00% | −52,001−90.9% | Reduced |
| Federated Hermes, Inc. | 4,551 | $860 | 0.00% | −1,238−21.4% | Reduced |
| Wells Fargo & Company | 2,933 | $554 | 0.00% | +19+0.7% | Added |
| Bank of America Corp | 1,335 | $252 | 0.00% | +239+21.8% | Added |
| Money Concepts Capital Corp | 50 | $9 | 0.00% | +50 | New |
| Larson Financial Group LLC | 8 | $2 | 0.00% | 00.0% | Unchanged |
| US Bancorp | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 511 | $0 | 0.00% | +32+6.7% | Added |
| Simplex Trading, LLC | 91 | $0 | 0.00% | −4,106−97.8% | Reduced |
| Allworth Financial LP | 1 | $0 | 0.00% | 00.0% | Unchanged |
| JFS Wealth Advisors, LLC | 2 | $0 | 0.00% | 00.0% | Unchanged |
| TSFG, LLC | 21 | $0 | 0.00% | 00.0% | Unchanged |
| CVA Family Office, LLC | 1 | $0 | 0.00% | 00.0% | Unchanged |
| GWM Advisors LLC | 435 | $0 | 0.00% | +435 | New |
| IFP Advisors, Inc | 2,200 | – | – | +1,000+83.3% | Added |
| Sabby Management, LLC | 0 | $0 | 0.00% | −1,262,516−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −582,500−100.0% | Sold out |
| Ayrton Capital LLC | 0 | $0 | 0.00% | −452,221−100.0% | Sold out |
| CVI Holdings, LLC | 0 | $0 | 0.00% | −141,877−100.0% | Sold out |
| Warberg Asset Management LLC | 0 | $0 | 0.00% | −65,002−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −56,389−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −20,515−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −12,000−100.0% | Sold out |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −524−100.0% | Sold out |
| Harbour Investments, Inc. | 0 | $0 | 0.00% | −8−100.0% | Sold out |
| Optimum Investment Advisors | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| TCI Wealth Advisors, Inc. | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Focused Wealth Management, Inc | 0 | $0 | 0.00% | −1,209−100.0% | Sold out |
| JJJ Advisors Inc. | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Aspire Private Capital, LLC | 0 | $0 | 0.00% | −5−100.0% | Sold out |